Jaeb Center for Health Research clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 129 studies whose lead sponsor is Jaeb Center for Health Research. 16 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Jaeb Center for Health Research studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Jaeb Center for Health Research leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 129. Browse all 129 →
- Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation RetinopathyRecruitingNCT05844982Phase 3
- Longitudinal Natural History Study of Retinal Function in Eyes of Patients With DiabetesRecruitingNCT07270133
- Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF AgentsRecruitingNCT07567833Phase 4
- Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDRRecruitingNCT06790784Phase 3
- Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic VariantsRecruitingNCT05589714
- Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric ChalaziaNot yet recruitingNCT07496515Phase 2
- Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERMRecruitingNCT05145491Not applicable
- Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin DeliveryRecruitingNCT06880835Not applicable
- A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia ControlRecruitingNCT07095894Phase 3
- A Study of Uveitis in Children <18 Years of AgeRecruitingNCT07518134
- A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PDNot yet recruitingNCT07470164Phase 3
- Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of AgeRecruitingNCT06524882Phase 3
- Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of AgeRecruitingNCT06380517Phase 3
- A Randomized Trial to Evaluate Sequential vs Simultaneous PatchingRecruitingNCT04378790Phase 3
- Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)RecruitingNCT06837181
- CGM for the Early Detection and Management of Hyperglycemia in PregnancyRecruitingNCT06957028Not applicable
- Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational DiabetesCompletedNCT06535789Phase 2/3
- Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young AdolescentsCompletedNCT02714972Not applicable
- Day and Night Closed-loop in Young People With Type 1 DiabetesCompletedNCT02925299Not applicable
- DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DMECompletedNCT03321513Phase 3
- Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension StudyCompletedNCT06177691
- Bionic Pancreas in CFRDActive, not recruitingNCT06449677Phase 3
- Strategies to Enhance New CGM Use in Early Childhood (SENCE)CompletedNCT02912728Not applicable
- Time in Glucose Hospital TargetCompletedNCT05135676Not applicable
- A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROPTerminatedNCT04634604Phase 3
- T1D Pregnancy & MeActive, not recruitingNCT06959316
- Gyrate Atrophy Ocular and Systemic StudyActive, not recruitingNCT05312736
- Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive AlgorithmsCompletedNCT02438189Not applicable
- Rate of Progression in EYS Related Retinal DegenerationCompletedNCT04127006
- Full-Time Occlusion Therapy for Intermittent Exotropia in ChildrenCompletedNCT05462821Phase 3
- Low-Dose Atropine for Treatment of MyopiaCompletedNCT03334253Phase 3
- Rate of Progression in USH2A-related Retinal DegenerationActive, not recruitingNCT03146078
- CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)CompletedNCT03263494Phase 3
- Trial of Overminus Spectacle Therapy for Intermittent ExotropiaCompletedNCT02807350Not applicable
- Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent ExotropiaCompletedNCT01032603Not applicable
- Binocular Dig Rush Game Treatment for AmblyopiaCompletedNCT02983552Not applicable
- Correction of Myopia Evaluation Trial 2CompletedNCT00320593Phase 3
- Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMDActive, not recruitingNCT05904028Phase 3
- Fenofibrate for Prevention of DR WorseningActive, not recruitingNCT04661358Phase 3
- Strength and Muscle Related Outcomes for Nutrition and Lung Function in CFActive, not recruitingNCT05639556
- Bevacizumab Treatment For Type 1 ROPActive, not recruitingNCT04634578Phase 2
- Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1FActive, not recruitingNCT04765345
- Evaluation of Tonabersat for DMEActive, not recruitingNCT05727891Phase 2
- Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at NearWithdrawnNCT05527015Phase 3
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)CompletedNCT01331005Phase 2
- The Insulin-Only Bionic Pancreas Pivotal TrialCompletedNCT04200313Not applicable
- Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)CompletedNCT04016662Phase 4
- Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 DiabetesCompletedNCT04233034Phase 3
- Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose MonitoringCompletedNCT04765358Not applicable
- Loop T2D Observational StudyCompletedNCT05951569